Northrop Grumman’s latest quarter was marked by steady operational execution and robust customer demand, as the company delivered sales growth across key segments and ended the year with a record backlog. Management credited solid execution in its Aeronautics, Defense, Mission, and Space Systems divisions for the performance, highlighting increased production on major programs such as the B-21 bomber and tactical missile systems. CEO Kathy Warden noted that, “Our backlog has grown by nearly $20 billion since 2021,” emphasizing the company’s alignment with evolving national security priorities and its capacity to deliver advanced defense solutions.
Is now the time to buy NOC? Find out in our full research report (it’s free for active Edge members).
Northrop Grumman (NOC) Q4 CY2025 Highlights:
- Revenue: $11.71 billion vs analyst estimates of $11.63 billion (9.6% year-on-year growth, 0.7% beat)
- Adjusted EPS: $7.23 vs analyst estimates of $6.96 (3.8% beat)
- Adjusted EBITDA: $1.68 billion vs analyst estimates of $1.63 billion (14.3% margin, 2.6% beat)
- Adjusted EPS guidance for the upcoming financial year 2026 is $27.65 at the midpoint, missing analyst estimates by 4.1%
- Operating Margin: 10.9%, in line with the same quarter last year
- Backlog: $95.68 billion at quarter end, up 4.6% year on year
- Organic Revenue rose 10.1% year on year (beat)
- Market Capitalization: $97.22 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions.
Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated.
Here is what has caught our attention.
Our Top 5 Analyst Questions From Northrop Grumman’s Q4 Earnings Call
- Ronald Epstein (Bank of America) asked about Northrop Grumman’s transformation toward nontraditional, rapid capability delivery. CEO Kathy Warden explained the company is leveraging its engineering talent and expanding capacity to field products more quickly, balancing performance with affordability.
- Sheila Kahyaoglu (Jefferies) pressed about growth acceleration tied to the FY27 defense budget and international demand. Warden responded that international book-to-bill is expected to exceed one, positioning Northrop Grumman for continued growth into 2027.
- Kristine Liwag (Morgan Stanley) questioned conservatism in the 2026 outlook despite a record backlog. Warden described the guidance as a balanced approach, noting that the timing of certain major contract awards is uncertain and upside may materialize over the next 24 months.
- Scott Deuschle (Deutsche Bank) asked for clarity on flat volumes for GEM 63 despite recent awards. Former CFO Ken Crews clarified that capacity is still being expanded and growth is expected to resume in 2027 as new production comes online.
- John Godden (Citi) explored the expected quarterly cadence of organic growth. Warden explained that sales growth will accelerate through the year, with Q1 affected by fewer working days and material timing, but momentum should build in subsequent quarters.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be monitoring (1) the ramp-up of production capacity for solid rocket motors and missile systems, (2) execution and conversion of the growing international contract pipeline, especially in air and missile defense, and (3) the timing of key program awards and transitions from development to production, such as B-21 acceleration. Progress in capacity expansion and successful contract wins will be key indicators of Northrop Grumman’s ability to sustain growth.
Northrop Grumman currently trades at $685.39, up from $660.97 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as
Nvidia (+1,326% between June 2020 and June 2025)
as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.